iSpecimen Inc. (ISPC) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, iSpecimen Inc.'s filing signal continuing negative.

iSpecimen operates a global marketplace platform connecting life science researchers with human biospecimens and associated data. The company's technology consolidates biospecimen procurement into a single online platform, aiming to accelerate medical discovery by simplifying the process for both researchers and healthcare providers. The platform leverages a robust dataset derived from electronic medical records and other healthcare data sources to facilitate searches and matchmaking. iSpecimen handles marketing, sales, contracting, and compliance for its users, aiming to transform the fragmented biospecimen procurement market. As of December 31, 2025, the platform had facilitated the delivery of over 218,000 specimens for more than 3,500 projects across 23 countries.

Revenue is generated by procuring and distributing annotated biospecimens to research clients, with revenue shared back with the healthcare providers who supplied them.